Health
Cleavage site recognition by SARS-CoV-2 main protease as new antiviral drug target – News-Medical.Net
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a…
The main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cleaves the proteins produced by the virus at various stages of replication and maturation. Highly conserved across coronaviruses due to the essential functional role of the enzyme, it also makes an appealing drug target.
Many research groups have and are investigating main protease inhibitors as antiviral drugs, and in a paper recently uploaded to the bioRxiv* preprint server, a team of researchers examine the crystal…
-
Noosa News19 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business22 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Business24 hours agoWhere will Nvidia stock be in 1 year?
-
General18 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands